Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance — Re:DriVR  

Stroke Clinical Trial

Official title: Effectiveness of Audiovisual Stimulation in Immersive Virtual Reality to Improve Visual Perception and Driving Performance: a Pilot Study

Status Not yet recruiting

Clinical Trial Summary

The goal of this clinical trial is to evaluate the effectiveness of an immersive virtual-reality (IVR) based stimulation program, in improving visual perception for people who have lost their driver's license due to perceptual or cognitive impairments.

The main questions it aims to answer are:

1. Can the 6-week IVR stimulation program help improve driving performance?

2. Will participants experience improvement in visual detection and perception after training?

Study Design Summary:

• Participants will be randomized into a waitlist group or intervention-first group

• The VR-based intervention will consist of training every 2 days for six weeks

• Waitlist group will wait 6 weeks before starting intervention at study midpoint (week 7)

• Intervention-first group will begin with intervention (week 1-6) and then stop intervention at study midpoint

• Participants will complete tests related to driving performance, visual attention, and visual fields at the start of study, midpoint, and end of study

Researchers will analyze data for changes from baseline in outcome measures.

Clinical Trial Description

This clinical trial will be an interventional, cross-over, single blind, randomized, supportive care, single-center study lasting 12 weeks with a target recruitment of 30 participants.

SCREENING AND BASELINE TESTS

Potential participants will be identified from patients receiving routine care at Toronto Western Hospital by their ophthalmologist. After obtaining informed consent and screened for inclusion, the research coordinator will set up appointments for each participant to complete baseline tests related to driving performance, visual attention, and visual fields. Participants will also practice the IVR program and be assessed for IVR sensitivity, or cybersickness, using the Virtual-Reality Induced Symptoms and Effects (VRISE) questionnaire.

Participants will be randomized into a Waitlist group or Intervention-First group. The Intervention-First group will be given a head-mounted display (HMD) to take home for training.

INTERVENTION (Week 1 - 12)

Period 1 (Week 1-6):

• Waitlist Group has no intervention

• Intervention-First group trains at home every 2 days using HMD

All participants are booked for their second appointments to repeat baseline tests once Period 1 is complete. Intervention-first group will return their HMD to the researchers and Waitlist group will be given their HMD to take home.

Period 2 (Week 7-12)

• Waitlist Group trains at home every 2 days using HMD

• Intervention-First group has no intervention

All participants are booked for their third appointments to repeat baseline tests once Period 2 is complete. Waitlist group will return their HMD to researchers.

POST-INTERVENTION

Analysis of outcome measures:

1. Period 1 (Waitlist Group vs Intervention-First Group)

2. Waitlist Group (Period 1 vs Period 2)

3. Intervention-First Group (Period 1 vs Period 2) ;

Related Conditions & MeSH terms

• Cognitive Impairment
• Driving Impaired
• Low Vision
• Stroke
• Virtual Reality
• Vision Disorders
• Vision, Low
• Visual Field Defect
• Visual Impairment
• Visual Processing Speed
• Visual Spatial Processing

• NCT number: NCT05703360
• Study type: Interventional
• Source: University Health Network, Toronto
• Contact: Danielle Tchao
• Phone: 647-408-9638
• Email: danielle.tchao@uhn.com
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 1, 2023
• Completion date: December 1, 2024